Login / Signup

Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply.

Laura Rindom KrogsgaardM LyngesenP Bytzer
Published in: Alimentary pharmacology & therapeutics (2017)
Keyphrases
  • irritable bowel syndrome
  • clinical trial
  • physical activity
  • weight loss
  • phase ii
  • open label
  • randomized controlled trial
  • phase iii
  • double blind